Clovis Oncology (CLVS) Gains Again Amid Continued Takeover Chatter
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Rumored takeover target Clovis Oncology (NASDAQ: CLVS) is gaining again. Shares are up 5.5%. Shares are up 189% over the last 3 months, up 109% over the last month and up 23% over the last 5 days.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Chardan Capital Markets Starts Clovis Oncology (CLVS) at 'Sell' With Price Target of $15
- Disney (DIS) on Watch Amid Unconfirmed Rumors of Spin-Off
- Schneider Electric Refutes Rumors Related to Rockwell Automation (ROK)
Create E-mail Alert Related CategoriesMergers and Acquisitions, Rumors, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!